United States President Joe Biden has announced that approximately five million COVID-19 vaccines will be supplied to Africa through COVAX, working in coordination with the African Union and the Africa Centres for Disease Control and Prevention.
The U.S., which has committed $4 billion to support COVAX last month announced that by the end of June, it will share 80 million doses of its vaccine supply with the world.
.@POTUS on sharing vaccine supply: “Nearly 19 million will be shared through COVAX, including approximately 6 million doses for Latin America & the Caribbean, approximately 7 million for South & Southeast Asia, & approximately 5 million for Africa.” More: https://t.co/aGlLrXdTb3.
— Department of State (@StateDept) June 3, 2021
The latest communique from the Biden administration provides more detail on how the first 25 million of those vaccines will be allocated, to lay the ground for increased global coverage and to address real and potential surges, high burdens of disease, and the needs of the most vulnerable countries.
At least 75 percent of these doses—nearly 19 million—will be shared through COVAX, including approximately six million doses for Latin America and the Caribbean, approximately seven million for South and Southeast Asia, and the five million for Africa.
The remaining doses, just over six million, will be shared directly with countries experiencing surges, those in crisis, and other partners and neighbors, including Canada, Mexico, India, and the Republic of Korea.
“We are sharing these doses not to secure favors or extract concessions. We are sharing these vaccines to save lives and to lead the world in bringing an end to the pandemic, with the power of our example and with our values,” a statement from the U.S. State Department read.